Bevacizumab improves survival in metastatic colorectal cancer patients with primary tumor resection: A meta-analysis

It is not well determined whether primary tumor resection is associated with better outcomes in metastatic colorectal cancer (mCRC) patients treated with bevacizumab. In this meta-analysis, we aimed to assess the prognostic role of primary tumor resection in mCRC treated with bevacizumab. Electronic...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Dedong, Zheng, Yongfa, Xu, Huilin, Ge, Wei, Xu, Ximing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937309/
https://www.ncbi.nlm.nih.gov/pubmed/31889159
http://dx.doi.org/10.1038/s41598-019-56528-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937309/
https://www.ncbi.nlm.nih.gov/pubmed/31889159
http://dx.doi.org/10.1038/s41598-019-56528-2

Ejemplares similares